Supplemental Vitamins and Minerals for Cardiovascular Disease Prevention and Treatment: JACC Focus Seminar

David J A Jenkins1, J David Spence2, Edward L Giovannucci3

  • 1Department of Nutritional Sciences, Temerty, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada; Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada; Toronto 3D Knowledge Synthesis and Clinical Trials Unit, St. Michael's Hospital, Toronto, Ontario, Canada; Clinical Nutrition Risk Factor Modification Centre, St. Michael's Hospital, Toronto, Ontario, Canada; Division of Endocrinology and Metabolism, St. Michael's Hospital, Toronto, Ontario, Canada.

Insights

Vitamin and mineral supplements show limited benefits for cardiovascular health. Folic acid and B vitamins may prevent stroke, but multivitamins, vitamin D, calcium, and vitamin C show no effect. Niacin with statin increased mortality risk.

Area of Science:

  • Nutrition Science
  • Cardiovascular Health
  • Evidence-Based Medicine

Background:

  • Systematic reviews and meta-analyses are crucial for evaluating vitamin and mineral supplementation effects.
  • Previous research in 2018 highlighted specific benefits and risks of supplementation.
  • Understanding the impact of supplements on cardiovascular disease (CVD) outcomes and mortality remains a public health priority.

Purpose of the Study:

  • To provide an updated systematic review and meta-analysis of vitamin and mineral supplementation on cardiovascular disease outcomes and all-cause mortality.
  • To synthesize evidence from new randomized controlled trials (RCTs) and meta-analyses published since the last review.
  • To assess the quality of evidence using the Grading of Recommendations Assessment Development and Evaluation (GRADE) approach.

Main Methods:

  • Conducted comprehensive literature searches in Cochrane Library, Medline, and Embase.
  • Analyzed data using random effects models to account for heterogeneity.
  • Classified evidence quality according to the GRADE approach to assess certainty of findings.

Main Results:

  • Folic acid and B vitamins demonstrated preventive benefits for stroke, with moderate quality evidence.
  • Commonly used supplements including multivitamins, vitamin D, calcium, and vitamin C showed no significant effect on CVD outcomes or mortality.
  • Niacin, when used in conjunction with statins, was associated with an increased risk of all-cause mortality.

Conclusions:

  • Supplementation with folic acid and B vitamins may offer a moderate-quality benefit for stroke prevention.
  • There is a lack of conclusive evidence for the benefits of most vitamin and mineral supplements, especially when dietary intake is sufficient.
  • Niacin in combination with statins requires caution due to an increased risk of all-cause mortality.

Related Concept Videos

Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...